We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.02B
AUM Growth
+$4.67M
Cap. Flow
+$2.09M
Cap. Flow %
0.21%
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$880K
2
WLY icon
John Wiley & Sons Class A
WLY
+$642K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$597K
4
USB icon
US Bancorp
USB
+$563K
5
CVX icon
Chevron
CVX
+$444K

Top Sells

Rank Stock Value
1
DOX icon
Amdocs
DOX
+$566K
2
SYK icon
Stryker
SYK
+$501K
3
MSFT icon
Microsoft
MSFT
+$415K
4
ARRY
Array Biopharma Inc
ARRY
+$369K
5
GS icon
Goldman Sachs
GS
+$321K

Sector Composition

Rank Sector Weight
1 Technology 25.57%
2 Healthcare 17.23%
3 Financials 11.97%
4 Consumer Staples 10.84%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TJX icon
76
TJX Companies
TJX
$179B
$1.63M 0.16%
29,268
– –
ADP icon
77
Automatic Data Processing
ADP
$109B
$1.62M 0.16%
10,063
– –
NTR icon
78
Nutrien
NTR
$33.9B
$1.54M 0.15%
30,960
– –
HON icon
79
Honeywell
HON
$76.4B
$1.52M 0.15%
9,512
-91
-0.9% -$14.5K
ABT icon
80
Abbott
ABT
$188B
$1.42M 0.14%
16,952
– –
COST icon
81
Costco
COST
$432B
$1.38M 0.14%
4,799
– –
T icon
82
AT&T
T
$164B
$1.3M 0.13%
45,425
-952
-2% -$25.2K
VRTX icon
83
Vertex Pharmaceuticals
VRTX
$123B
$1.19M 0.12%
7,007
+415
+6% +$73.4K
HD icon
84
Home Depot
HD
$337B
$1.15M 0.11%
4,975
+150
+3% +$32.8K
KMB icon
85
Kimberly-Clark
KMB
$37.6B
$1.15M 0.11%
8,073
-190
-2% -$26.1K
GOOGL icon
86
Alphabet (Google) Class A
GOOGL
$4.12T
$1.13M 0.11%
18,580
– –
SGEN
87
DELISTED
Seagen Inc. Common Stock
SGEN
$1.13M 0.11%
13,235
+1,010
+8% +$74K
RTX icon
88
RTX Corp
RTX
$290B
$1M 0.1%
11,687
-2,848
-20% -$236K
GOOG icon
89
Alphabet (Google) Class C
GOOG
$4.11T
$1M 0.1%
16,440
– –
FAST icon
90
Fastenal
FAST
$54.8B
$966K 0.1%
59,140
– –
EMR icon
91
Emerson Electric
EMR
$81.6B
$954K 0.09%
14,273
-50
-0.3% -$3.14K
IONS icon
92
Ionis Pharmaceuticals
IONS
$8.93B
$948K 0.09%
15,821
+1,170
+8% +$76.3K
IBM icon
93
IBM
IBM
$213B
$944K 0.09%
6,790
-307
-4% -$41.4K
BP icon
94
BP
BP
$112B
$938K 0.09%
24,703
-476
-2% -$18.2K
BDX icon
95
Becton Dickinson
BDX
$46.4B
$918K 0.09%
3,721
– –
GE icon
96
GE Aerospace
GE
$364B
$894K 0.09%
20,059
– –
CTRA
97
DELISTED
Coterra Energy
CTRA
$880K 0.09%
50,104
– –
NBIX icon
98
Neurocrine Biosciences
NBIX
$18.2B
$853K 0.08%
9,466
+855
+10% +$79.9K
VPL icon
99
Vanguard FTSE Pacific ETF
VPL
$7.77B
$849K 0.08%
12,848
– –
ISRG icon
100
Intuitive Surgical
ISRG
$127B
$835K 0.08%
4,638
– –
2 3
4
5 6

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2019 Portfolio in Review

As of Q3 2019, Grandfield & Dodd held 183 positions worth $1.02B, up 0.46% from $1.01B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Grandfield & Dodd opened 2 new positions and exited 6, leaving the 183-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2019 buy was iShares Russell 1000 Growth ETF: 5,832 shares worth $233K.
  • Grandfield & Dodd added most to Blackbaud in Q3 2019, an estimated $880K increase.
  • Grandfield & Dodd's biggest Q3 2019 reduction was Amdocs, cutting an estimated $566K.
  • Grandfield & Dodd fully exited Array Biopharma Inc in Q3 2019, selling an estimated $369K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.02B portfolio in Q3 2019.
  • Grandfield & Dodd opened 2 new positions and closed 6 in Q3 2019.
  • Grandfield & Dodd's portfolio value rose 0.46% quarter-over-quarter to $1.02B.

Based on Grandfield & Dodd's 13F filing for Q3 2019, filed 30 Oct 2019.